Title:
チロシンキナーゼ阻害剤を含む眼内インプラント
Document Type and Number:
Japanese Patent JP7378638
Kind Code:
B2
Abstract:
The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
Inventors:
Blizzard, Charles, Dee.
Driscoll, Arthur
El-Hayek, Rami
goldstein, michael
Iacona, Joseph
Jarrett, Peter
Jarrett, Timothy, S.
Khan, Erica
Luttrell, Zatchery
Driscoll, Arthur
El-Hayek, Rami
goldstein, michael
Iacona, Joseph
Jarrett, Peter
Jarrett, Timothy, S.
Khan, Erica
Luttrell, Zatchery
Application Number:
JP2022557121A
Publication Date:
November 13, 2023
Filing Date:
March 24, 2021
Export Citation:
Assignee:
Ocula Therapeutics, Incorporated
International Classes:
A61L27/54; A61K9/06; A61K31/4439; A61K45/00; A61K47/10; A61L27/18; A61L27/28; A61L27/52; A61P27/02; A61P43/00
Domestic Patent References:
| JP2017537130A |
Foreign References:
| US20180085307 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Kyoei Sugiyama
Norio Omori
Kyoei Sugiyama
Previous Patent: Fault diagnosis device, learning device, learning method, and fault diagnosis system
Next Patent: Road wall shape estimation method
Next Patent: Road wall shape estimation method